Decision support tool cuts hypoglycemia risk in older adults
Oct 11, 2023
A decreased use of insulin and sulfonylureas was seen postintervention.
FDA approves updated Novavax COVID-19 vaccine
Oct 04, 2023
The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.
‘Deltacron’ variant rare and not a major concern
Mar 14, 2022
The hybrid is extremely rare and has not yet shown the ability to spread exponentially.
REGEN-COV reduces risk for COVID-19 hospitalization, death
Oct 01, 2021
Among outpatients with COVID-19 at high risk, the risk for hospitalization and death was reduced with the monoclonal antibody combo versus placebo.
Overestimation of oxygen saturation leads to delayed COVID-19 treatment
Aug 31, 2023
Patients with unrecognized need for COVID-19 therapy appear to have higher odds of readmission, regardless of race.
‘Stealth’ version of omicron variant no cause for alarm, experts say
Jan 31, 2022
The new version of the variant does not appear to cause more severe disease, and vaccines are effective against it.
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
California Legislature first to pass ban on four food additives linked to health issues
Sep 13, 2023
The chemicals already are illegal in the European Union and other places around the world.
mRNA Vaccine more effective booster to ChAdOx1 nCoV-19
Oct 22, 2021
“Our study shows a greater risk reduction for people who received an mRNA vaccine after having received a first dose of a vector-based, as compared to people having received the vector-based vaccine...
Lorundrostat effective for lowering BP in uncontrolled hypertension
Sep 15, 2023
Changes in office systolic BP of −14.1, −13.2, −6.9 and −4.1 mm Hg were seen with 100, 50, 12.5 mg once daily of lorundrostat and placebo.